The HPOs will receive $13.8 million to enroll people interested in the All of Us program, gather participant health information, and help retain participants.
This story has been updated from a version published Aug. 15 to reflect the fact that Iverson Genetics has not yet selected a testing partner for the WARFARIN trial.
Morehouse School of Medicine will use the NIH funding and work with several partners to start a minority database focused first on hypertension and personalized medicine.
A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.
In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.
